Skip to main content

KdT Ventures — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

57
Companies
$805.4M
Total invested
$14.1M
Avg. check
34
Industries
Biotechnology 15Health Care 12Medical 8Therapeutics 7Life Science 5Manufacturing 3+28 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 57
Transcera
July 2023

Transcera is a biotechnology company that uses a new approach to biological drug delivery to transform the treatment of chronic diseases.

Biotechnology · Jamaica PlainSeed
SURGE Therapeutics
July 2023

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

Biotechnology · Cambridge$32.0M Series B
Unravel Biosciences
March 2023

The first rapid prototyping therapeutics company

Biotechnology · Boston$550K Grant
Andes
March 2023

Andes develops an integrated microbial technology to help accelerate crop growth.

Agriculture · Alameda$15.0M Series A
Checkerspot
February 2023

Checkerspot is a biology driven, molecule licensing company designing fats and oils through precision fermentation.

Biotechnology · Alameda$55.0M Series C
Tavros Therapeutics
October 2022

Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.

Biotechnology · Durham$17.5M Corporate Round
Hi Fidelity Genetics
December 2021

Hi Fidelity Genetics is a start up based in Durham, NC.

Hardware · ShepherdConvertible Note
Parthenon Therapeutics
November 2021

Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.

Biotechnology · Cambridge$65.0M Series A
Modulus Therapeutics
July 2021

Modulus Therapeutics is an artificial-intelligence-powered cell therapy design company.

Artificial Intelligence (AI) · Seattle$3.5M Seed
MacroCycle Technologies
March 2026

MacroCycle Technologies is a cleantech company that develops sustainable and zero-carbon plastic upcycling solutions.

CleanTech · Cambridge$3.0M Seed
Azitra
November 2025

Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.

Alternative Medicine · Branford$1.5M Post Ipo Equity
Skeletalis
November 2025

Skeletalis develops precision medicines targeting bone loss to treat osteoporosis and prevent fractures safely.

Biotechnology · Boston$8.0M Seed
Montara Therapeutics
May 2025

Montara Therapeutics offers a platform to prevent peripheral toxicities and concentrate neurological drugs’ activity in the brain.

Biopharma · San Francisco$3.3M Grant
Zymochem
May 2025

Zymochem provides a carbon-efficient bio-manufacturing platform that converts renewable feedstocks into bio-based materials.

Biotechnology · San LeandroSeries Unknown
March Biosciences
April 2025

March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.

Biotechnology · Houston$200K Grant
PHNX Materials
April 2025

PHNX Materials is a manufacturing company that specializes in turning waste into essential materials and reduce carbon emissions.

Environmental Engineering · San Francisco$2.5M Seed
Reverb Therapeutics
February 2025

Reverb Therapeutics engages in the development of treatments for cancer and other diseases.

Health Care · Vancouver$12.0M Seed
Rarebird
February 2025

Rarebird is a coffee company featuring Arabica coffee beans that deliver improved mental wellness outcomes.

Coffee · San Leandro$1.0M Series Unknown
Rejuvenate Bio
July 2024

Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases.

Biotechnology · San Diego$4.0M Grant
Radar Therapeutics
May 2024

Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics.

Medical · Berkeley$13.4M Seed
Motif Neurotech
January 2024

Motif Neurotech is a company that develops minimally invasive bioelectronic implants for monitoring and treating severe mental illnesses.

Health Care · Houston$18.8M Series A
Aperiam Bio
November 2023

Aperiam Bio partners with enzyme engineers to create and share stabilized, solubilized, and catalytically optimized proteins.

Biotechnology · Austin$9.0M Seed
Cypris Materials
November 2023

Cypris Materials is a developer of color for the paints, inks, and coatings sectors.

Chemical · Berkeley$3.2M Series Unknown
Canaery
July 2023

Canaery is builds a neural interface for analyzing an object’s scent fingerprint to identify dangerous compounds.

Information Technology · AlachuaSeed

Where KdT Ventures invests

Biotechnology15
Health Care12
Medical8
Therapeutics7
Life Science5
Manufacturing3

About KdT Ventures's portfolio

How many companies has KdT Ventures invested in?▸

KdT Ventures has invested in 57 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does KdT Ventures invest in?▸

KdT Ventures's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 34 different industry categories.

What is KdT Ventures's largest investment?▸

Among tracked funding rounds, Parthenon Therapeutics received $65.0M in a Series A round. KdT Ventures's total known invested capital is $805.4M.

What is the average investment size for KdT Ventures?▸

KdT Ventures's average investment size is $14.1M across its portfolio of 57 companies.

What are KdT Ventures's most recent investments?▸

Recent KdT Ventures portfolio additions include Transcera, SURGE Therapeutics, Unravel Biosciences, Andes, Checkerspot. These companies were founded in 2020 or later.

Reach the founders behind these 57 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →